Cargando…
Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288409/ http://dx.doi.org/10.1186/2051-1426-2-S3-P116 |
_version_ | 1782351966536466432 |
---|---|
author | O'Brien, Morgan Forde, Patrick Power, Derek Soden, Declan |
author_facet | O'Brien, Morgan Forde, Patrick Power, Derek Soden, Declan |
author_sort | O'Brien, Morgan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4288409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42884092015-01-15 Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis O'Brien, Morgan Forde, Patrick Power, Derek Soden, Declan J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288409/ http://dx.doi.org/10.1186/2051-1426-2-S3-P116 Text en Copyright © 2014 Brien et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation O'Brien, Morgan Forde, Patrick Power, Derek Soden, Declan Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis |
title | Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis |
title_full | Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis |
title_fullStr | Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis |
title_full_unstemmed | Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis |
title_short | Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis |
title_sort | electrochemotherapy and inducible t cell co-stimulator (icos) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288409/ http://dx.doi.org/10.1186/2051-1426-2-S3-P116 |
work_keys_str_mv | AT obrienmorgan electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis AT fordepatrick electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis AT powerderek electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis AT sodendeclan electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis |